See the DrugPatentWatch profile for amikacin
Amikacin is available under the brand name Amikin [1].
What is Amikin used for?
Amikin is an aminoglycoside antibiotic used to treat serious bacterial infections [1]. It is effective against a range of Gram-negative bacteria and some Gram-positive bacteria [1].
How does amikacin work?
Amikacin works by inhibiting protein synthesis in bacteria. It binds to the bacterial ribosome, specifically the 30S ribosomal subunit, which disrupts the process of translating messenger RNA into proteins [2]. This ultimately leads to bacterial cell death [2].
Are there other amikacin brands or generics?
While Amikin is the primary brand name, amikacin is also available as a generic medication [3]. The availability of generic versions can impact pricing and accessibility [3].
What are the potential side effects of amikacin?
Like other aminoglycosides, amikacin can cause serious side effects, including kidney damage (nephrotoxicity) and hearing loss or balance problems (ototoxicity) [1]. Monitoring kidney function and hearing is important during treatment [1]. Other side effects may include nausea, vomiting, and rash [1].
What is the patent status for amikacin?
Amikacin is an older drug, and its primary patents have long expired. This has allowed for the development and availability of generic amikacin products [4]. Information on specific patents and their expiration dates can be found on resources like DrugPatentWatch.com [4].
Who manufactures Amikin?
Amikin was originally developed and marketed by Bristol-Myers Squibb [1]. The manufacturer of generic amikacin products can vary among pharmaceutical companies [3].
How is amikacin administered?
Amikacin is typically administered intravenously (IV) or intramuscularly (IM) by a healthcare professional [1]. It is not usually taken orally as it is not well absorbed from the gastrointestinal tract [2].
When does amikacin patent expiry matter?
For older drugs like amikacin, patent expiry has already occurred, leading to generic competition. This is a common pathway for drug pricing to decrease and for wider availability of medications once market exclusivity periods end [4].
What are alternatives to amikacin for bacterial infections?
Treatment options depend on the specific bacteria causing the infection and the patient's condition. Other classes of antibiotics may be used, including other aminoglycosides, beta-lactams, macrolides, or fluoroquinolones, often in combination therapy [2].
---
Cited Sources:
1. https://www.drugs.com/medical-answers/amikacin-3053692/
2. https://www.ncbi.nlm.nih.gov/books/NBK459206/
3. https://www.ncbi.nlm.nih.gov/books/NBK541155/
4. https://drugpatentwatch.com/